{"id":3784,"date":"2019-09-26T11:30:00","date_gmt":"2019-09-26T11:30:00","guid":{"rendered":"http:\/\/www.irlab.se\/irlabs-irl790-foreslas-fa-unikt-inn-av-who\/"},"modified":"2019-09-26T11:30:00","modified_gmt":"2019-09-26T11:30:00","slug":"irlabs-irl790-foreslas-fa-unikt-inn-av-who","status":"publish","type":"post","link":"https:\/\/irlab.se\/sv\/irlabs-irl790-foreslas-fa-unikt-inn-av-who\/","title":{"rendered":"IRLAB:s IRL790 f\u00f6resl\u00e5s f\u00e5 unikt INN av WHO"},"content":{"rendered":"<p><span>INN-systemet &auml;r ett WHO-reglerat klassificeringssystem som har uppr&auml;ttats f&ouml;r att underl&auml;tta identifiering av farmaceutiska &auml;mnen eller aktiva l&auml;kemedelsingredienser p&aring; ett unikt och globalt erk&auml;nt s&auml;tt. Genom systemet f&aring;r sjukv&aring;rdspersonal en tydlig identifiering av ett l&auml;kemedel vilket m&ouml;jligg&ouml;r s&auml;ker f&ouml;rskrivning och utdelning av medicin till patienter. F&ouml;rslaget och rekommendationen av ett INN, &auml;ven k&auml;nd som ett generiskt namn, markerar d&auml;rf&ouml;r ett viktigt f&ouml;rberedande steg f&ouml;r en l&auml;kemedelskandidats marknadsgodk&auml;nnande och efterf&ouml;ljande lansering.<\/span><\/p>\n<p><span>Nicholas Waters, VD p&aring; IRLAB, kommenterade &rdquo;I INN systemet &auml;r relationen mellan farmakologiskt-associerade substanser identifierad genom en gemensam stam. Bara n&auml;r substanser visar en ny verkningsmekanism, vilket &auml;r relativt ovanligt, s&aring; uppr&auml;ttas en ny INN-stam. Vi &auml;r d&auml;rf&ouml;r mycket n&ouml;jda med att ha blivit f&ouml;reslagna &auml;ndelsen &rdquo;-dopetam&rdquo; f&ouml;r IRL790, vilket fram&ouml;ver kan komma att bli en stam. Detta skulle understryka kandidatens position som en potential first-in-class behandling vid Parkinsons sjukdom.&rdquo;<\/span><\/p>\n<p><span>Enligt WHO:s f&ouml;rordningar f&ouml;ljer efter publiceringen av ett f&ouml;reslaget INN en period p&aring; fyra m&aring;nader d&auml;r potentiella inv&auml;ndningar som st&ouml;ds av starka sk&auml;l kan l&auml;mnas in till WHO. Om ingen part inv&auml;nder mot INN blir det f&ouml;reslagna INN ett rekommenderat INN.<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>IRLAB meddelade idag att V\u00e4rldsh\u00e4lsoorganisationen (WHO) har f\u00f6reslagit namnet mesdopetam som ett \u2019International Nonproprietary Name\u2019 (INN) f\u00f6r bolagets l\u00e4kemedelskandidat IRL790. WHO drog slutsatsen att IRL790 \u00e4r helt unik i sin verkningsmekanism och d\u00e4rf\u00f6r beh\u00f6ver dess nya f\u00f6reslagna INN inte integreras i n\u00e5gon befintlig INN-stam i klassificeringssystemet. INN namnet kommer att tj\u00e4na till att identifiera den aktiva l\u00e4kemedelssubstansen i IRL790 under dess livstid \u00f6ver hela v\u00e4rlden bland sjukv\u00e5rdspersonal, forskare och patienter.<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[23],"tags":[],"class_list":["post-3784","post","type-post","status-publish","format-standard","hentry","category-pressmeddelande-2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>IRLAB:s IRL790 f\u00f6resl\u00e5s f\u00e5 unikt INN av WHO - IRLAB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/irlab.se\/sv\/irlabs-irl790-foreslas-fa-unikt-inn-av-who\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IRLAB:s IRL790 f\u00f6resl\u00e5s f\u00e5 unikt INN av WHO - IRLAB\" \/>\n<meta property=\"og:description\" content=\"IRLAB meddelade idag att V\u00e4rldsh\u00e4lsoorganisationen (WHO) har f\u00f6reslagit namnet mesdopetam som ett \u2019International Nonproprietary Name\u2019 (INN) f\u00f6r bolagets l\u00e4kemedelskandidat IRL790. WHO drog slutsatsen att IRL790 \u00e4r helt unik i sin verkningsmekanism och d\u00e4rf\u00f6r beh\u00f6ver dess nya f\u00f6reslagna INN inte integreras i n\u00e5gon befintlig INN-stam i klassificeringssystemet. INN namnet kommer att tj\u00e4na till att identifiera den aktiva l\u00e4kemedelssubstansen i IRL790 under dess livstid \u00f6ver hela v\u00e4rlden bland sjukv\u00e5rdspersonal, forskare och patienter.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/irlab.se\/sv\/irlabs-irl790-foreslas-fa-unikt-inn-av-who\/\" \/>\n<meta property=\"og:site_name\" content=\"IRLAB\" \/>\n<meta property=\"article:published_time\" content=\"2019-09-26T11:30:00+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/irlab.se\/sv\/irlabs-irl790-foreslas-fa-unikt-inn-av-who\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/irlab.se\/sv\/irlabs-irl790-foreslas-fa-unikt-inn-av-who\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"IRLAB:s IRL790 f\u00f6resl\u00e5s f\u00e5 unikt INN av WHO\",\"datePublished\":\"2019-09-26T11:30:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/irlab.se\/sv\/irlabs-irl790-foreslas-fa-unikt-inn-av-who\/\"},\"wordCount\":290,\"commentCount\":0,\"articleSection\":[\"Pressmeddelande\"],\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/irlab.se\/sv\/irlabs-irl790-foreslas-fa-unikt-inn-av-who\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/irlab.se\/sv\/irlabs-irl790-foreslas-fa-unikt-inn-av-who\/\",\"url\":\"https:\/\/irlab.se\/sv\/irlabs-irl790-foreslas-fa-unikt-inn-av-who\/\",\"name\":\"IRLAB:s IRL790 f\u00f6resl\u00e5s f\u00e5 unikt INN av WHO - IRLAB\",\"isPartOf\":{\"@id\":\"https:\/\/irlab.se\/#website\"},\"datePublished\":\"2019-09-26T11:30:00+00:00\",\"author\":{\"@id\":\"\"},\"breadcrumb\":{\"@id\":\"https:\/\/irlab.se\/sv\/irlabs-irl790-foreslas-fa-unikt-inn-av-who\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/irlab.se\/sv\/irlabs-irl790-foreslas-fa-unikt-inn-av-who\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/irlab.se\/sv\/irlabs-irl790-foreslas-fa-unikt-inn-av-who\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/irlab.se\/sv\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"IRLAB:s IRL790 f\u00f6resl\u00e5s f\u00e5 unikt INN av WHO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/irlab.se\/#website\",\"url\":\"https:\/\/irlab.se\/\",\"name\":\"Irlab\",\"description\":\"Novel treatments for Parkinson&#039;s disease\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/irlab.se\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IRLAB:s IRL790 f\u00f6resl\u00e5s f\u00e5 unikt INN av WHO - IRLAB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/irlab.se\/sv\/irlabs-irl790-foreslas-fa-unikt-inn-av-who\/","og_locale":"sv_SE","og_type":"article","og_title":"IRLAB:s IRL790 f\u00f6resl\u00e5s f\u00e5 unikt INN av WHO - IRLAB","og_description":"IRLAB meddelade idag att V\u00e4rldsh\u00e4lsoorganisationen (WHO) har f\u00f6reslagit namnet mesdopetam som ett \u2019International Nonproprietary Name\u2019 (INN) f\u00f6r bolagets l\u00e4kemedelskandidat IRL790. WHO drog slutsatsen att IRL790 \u00e4r helt unik i sin verkningsmekanism och d\u00e4rf\u00f6r beh\u00f6ver dess nya f\u00f6reslagna INN inte integreras i n\u00e5gon befintlig INN-stam i klassificeringssystemet. INN namnet kommer att tj\u00e4na till att identifiera den aktiva l\u00e4kemedelssubstansen i IRL790 under dess livstid \u00f6ver hela v\u00e4rlden bland sjukv\u00e5rdspersonal, forskare och patienter.","og_url":"https:\/\/irlab.se\/sv\/irlabs-irl790-foreslas-fa-unikt-inn-av-who\/","og_site_name":"IRLAB","article_published_time":"2019-09-26T11:30:00+00:00","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/irlab.se\/sv\/irlabs-irl790-foreslas-fa-unikt-inn-av-who\/#article","isPartOf":{"@id":"https:\/\/irlab.se\/sv\/irlabs-irl790-foreslas-fa-unikt-inn-av-who\/"},"author":{"name":"","@id":""},"headline":"IRLAB:s IRL790 f\u00f6resl\u00e5s f\u00e5 unikt INN av WHO","datePublished":"2019-09-26T11:30:00+00:00","mainEntityOfPage":{"@id":"https:\/\/irlab.se\/sv\/irlabs-irl790-foreslas-fa-unikt-inn-av-who\/"},"wordCount":290,"commentCount":0,"articleSection":["Pressmeddelande"],"inLanguage":"sv-SE","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/irlab.se\/sv\/irlabs-irl790-foreslas-fa-unikt-inn-av-who\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/irlab.se\/sv\/irlabs-irl790-foreslas-fa-unikt-inn-av-who\/","url":"https:\/\/irlab.se\/sv\/irlabs-irl790-foreslas-fa-unikt-inn-av-who\/","name":"IRLAB:s IRL790 f\u00f6resl\u00e5s f\u00e5 unikt INN av WHO - IRLAB","isPartOf":{"@id":"https:\/\/irlab.se\/#website"},"datePublished":"2019-09-26T11:30:00+00:00","author":{"@id":""},"breadcrumb":{"@id":"https:\/\/irlab.se\/sv\/irlabs-irl790-foreslas-fa-unikt-inn-av-who\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/irlab.se\/sv\/irlabs-irl790-foreslas-fa-unikt-inn-av-who\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/irlab.se\/sv\/irlabs-irl790-foreslas-fa-unikt-inn-av-who\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/irlab.se\/sv\/"},{"@type":"ListItem","position":2,"name":"IRLAB:s IRL790 f\u00f6resl\u00e5s f\u00e5 unikt INN av WHO"}]},{"@type":"WebSite","@id":"https:\/\/irlab.se\/#website","url":"https:\/\/irlab.se\/","name":"Irlab","description":"Novel treatments for Parkinson&#039;s disease","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/irlab.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/posts\/3784","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/comments?post=3784"}],"version-history":[{"count":0,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/posts\/3784\/revisions"}],"wp:attachment":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/media?parent=3784"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/categories?post=3784"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/tags?post=3784"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}